Hematology Diagnostics Market Expected to Reach US$ 7.6 Billion by 2030, Growing at 6.4% CAGR: Wissen Research
SHERIDAN, Wyo., May 14, 2026 /PRNewswire/ -- The global hematology diagnostics market is projected to grow from USD 6.1 billion in 2025 to USD 7.6 billion by 2030, registering a CAGR of 6.4% during the forecast period (2026–2030), according to a new study by Wissen Research.
The growing number of cases of blood diseases, increasing demand for disease diagnosis in the early stages, and growing use of automated diagnostic tools have been contributing towards the growth of the haematology diagnostics industry. The healthcare organizations and the diagnostic centers are adopting sophisticated haematology analyzers, flow cytometers, and molecular diagnostic tools to improve the accuracy of testing and efficiency of disease monitoring processes.
Request a Customized Version of This Report Based on Your Business Requirements: https://www.wissenresearch.com/ask-for-customization/
Technology Advancements Reshaping the Hematology Diagnostics Market
Advances in automation, digital imaging, flow cytometry, and molecular diagnostics technology are revolutionizing the haematology diagnostics industry. With advancements in technology, contemporary haematology analyzers are now able to perform complete blood counts (CBC), white blood cell differential, and other specialized disease diagnoses faster and more accurately without much human intervention. Artificial intelligence and analytics are playing critical roles in improving the detection of abnormal cells, workflow, and efficiency in laboratories.
Rising cases of anaemia, leukaemia, lymphoma, and infections have prompted health facilities to purchase advanced haematology testing equipment to detect these diseases early and accurately. Besides, advances in technology have led to the adoption of high throughput analyzers, point of care testing, and automation in labs, hence speeding up clinical decisions. Additionally, regulatory push towards standardized diagnostics and investment in precision medicines is spurring innovations in the haematology diagnostics industry.
Key Market Drivers for the Hematology Diagnostics Market:
Market Challenges for the Hematology Diagnostics Industry
Recent Strategic Developments in the Hematology Diagnostics Market
The deals being struck across the industry tell a clear story — companies are doubling down on enhanced automated analyzers, sophisticated flow cytometry, and refined optical and impedance detection methods, increasingly through partnerships rather than solo efforts.
In June 2025, Sysmex Corporation (Japan) received Health Canada licensing for its new CN-3000™ and CN-6000™ Automated Blood Coagulation Analyzers. These high-throughput, fully automated systems are designed to offer smart workflow features, a small footprint, and expandability to meet various laboratory needs. Sysmex highlights their ability to improve efficiency, accuracy, and patient care, particularly addressing workforce challenges. This development expands Sysmex's presence in the haemostasis testing segment of the haematology market in Canada.
In May 2025, Shenzhen Dymind Biotechnology Co., Ltd. (China) launched its DH-800 Haematology Analyzer and CA1200 Coagulation Analyzer during an event in Lima, Peru. The launch, held at the Westin Hotel, attracted over 120 key stakeholders, exceeding initial expectations. This marks Dymind's effort to advance diagnostics and build partnerships within the Peruvian healthcare market.
In April 2025, Sysmex Corporation (Japan) initiated full-scale operations at its new manufacturing base in India, capable of producing both diagnostic reagents and instruments. The company has begun manufacturing its XQ-320 Automated Haematology Analyzer in India to align with the local "Make in India" policy, targeting small and medium-sized medical institutions.
Key Insights from Hematology Diagnostics Market Analysis
Key Players in the Hematology Diagnostics Market
Leading companies in the hematology diagnostics market are focusing on product innovation, strategic collaborations, and expanding health-focused capabilities to strengthen their competitive position.
Company
Key Focus Area
SYSMEX CORPORATION (JAPAN)
Automated haematology analyzers and clinical laboratory diagnostics
SIEMENS HEALTHINEERS (GERMANY)
Integrated haematology systems and laboratory automation
HORIBA, LTD. (JAPAN)
Haematology analyzers and blood cell analysis solutions
DANAHER CORPORATION (US)
Clinical diagnostics and haematology workflow technologies
ABBOTT LABORATORIES (US)
Diagnostic instruments and point-of-care haematology testing
BIO-RAD LABORATORIES INC. (US)
Quality controls and haematology diagnostic systems
NIHON KOHDEN CORPORATION (JAPAN)
Haematology analyzers and laboratory diagnostic equipment
BOULE DIAGNOSTICS AB (SWEDEN)
Compact haematology analyzers and consumables
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CHINA)
Automated blood analysis and haematology diagnostics
F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)
Integrated diagnostics and digital laboratory solutions
EKF DIAGNOSTICS HOLDING PLC (UK)
Point-of-care haematology and haemoglobin testing
DREW SCIENTIFIC (US)
Haematology instrumentation and laboratory analyzers
DIATRON (HUNGARY)
Haematology analyzers and reagent development
Regional Analysis and Growth Opportunities in the Hematology Diagnostics Market
The North American region plays a dominant role in the hematology diagnostics market due to its advanced health infrastructure, widespread use of automated diagnostic tools, and high incidences of various blood-related diseases. Presence of leading diagnostic companies and increased automation trends among laboratory services drive regional market growth.
It is estimated that the Asia-Pacific region will witness significant growth in the future due to improved accessibility to healthcare facilities, increase in population size, and investment in laboratories in countries like China, India, and Japan. Growing awareness about early detection of disease conditions drives regional demand.
Europe is expected to register continuous growth due to established clinical laboratory services, reimbursement benefits for patients and healthcare providers, and increased use of haematology analyzers. In addition, Latin America and the Middle East & Africa are emerging regions owing to the development of their diagnostics sector.
Product & End Users Insights
Complete Blood Count (CBC) / Differential remained the leading core test type in the haematology diagnostics market in 2025 due to its widespread use in routine health screening, infection detection, anaemia diagnosis, and monitoring of hematologic disorders. CBC testing is among the most frequently performed laboratory tests globally, supported by growing adoption of automated haematology analyzers capable of delivering rapid and accurate multi-parameter blood analysis. Increasing prevalence of blood disorders, infectious diseases, and chronic conditions continues to sustain demand for CBC and differential testing across hospitals and diagnostic laboratories.
Disease diagnosis accounted for the largest application share in the hematology diagnostics market in 2025, driven by rising demand for early and accurate detection of anaemia, leukaemia, lymphoma, infections, and other blood-related disorders. Haematology diagnostics play a critical role in clinical decision-making by supporting disease identification, treatment monitoring, and patient management. Growing healthcare awareness, expanding diagnostic testing volumes, and increasing use of advanced automated analyzers are further supporting the dominance of diagnostic applications in the market.
To purchase the complete Hematology Diagnostics Market report and access detailed forecasts, competitive insights, and growth opportunities, visit: https://www.wissenresearch.com/Pricing/
Market Segmentation Snapshot
The global haematology diagnostics market is segmented across product, core tests, application, end users and regions:
• By Product Type:
• By Core Tests:
• By Application:
By End User Industries:
• By Region:
Advancements in automated haematology analyzers, flow cytometry, digital imaging, and AI-assisted diagnostics are significantly improving the speed, accuracy, and efficiency of blood analysis across clinical laboratories. Increasing integration of high-throughput systems, connectivity solutions, and advanced data analytics is enabling faster disease detection and streamlined laboratory workflows. For stakeholders in the haematology diagnostics market, continued opportunities lie in product innovation, expansion of point-of-care haematology testing, strategic collaborations with healthcare providers, and growing adoption of advanced diagnostic technologies in emerging healthcare markets.
Expert Profile | Mayur Jain, Wissen Research
Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry.
Email: [email protected]
LinkedIn: https://www.linkedin.com/in/mayur-jain-0190542a/
About Wissen Research
Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets
Company Contact:
Wissen Research LLC,
Gould St, Ste R,
Sheridan, WY 82801,
Phone: (+1) 510 240 9853
Email: [email protected]
Website: https://www.wissenresearch.com/
Blog: https://www.wissenresearch.com/insights/
LinkedIn: https://www.linkedin.com/company/wissen-research
Logo - https://mma.prnewswire.com/media/2971885/5971203/Wissen_Research_Logo.jpg
SOURCE Wissen Research LLC